Literature DB >> 18046488

The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.

Zheng Huang1, Qun Chen, Kenneth C Dole, Al B Barqawi, Yang K Chen, Dominique Blanc, Brian C Wilson, Fred W Hetzel.   

Abstract

Photodynamic therapy (PDT) mediated with vascular acting photosensitizer Tookad (Pd-bacteriopheophorbide) was investigated as an alternative modality for treating prostate cancer. Photodynamic effects on the prostate gland and its adjacent tissues were evaluated in a canine model. Interstitial prostate PDT was performed by irradiating individual lobes with a cylindrical diffuser fiber at various drug/light doses. The sensitivity of the adjacent tissues to Tookad PDT was determined by directly irradiating the surface of the bladder, colon, abdominal muscle and pelvic plexus with a microlens fiber at various drug/light doses. The prostate and adjacent tissues were harvested one-week after the treatment and subjected to histopathological examination. PDT-induced prostate lesions were characterized by marked hemorrhagic necrosis. The bladder, colon, abdominal muscle and pelvic plexus appeared to be sensitive to PDT although the Tookad PDT-induced responses in these tissues were minimal compared to that of the prostate gland at the same dose levels. Nevertheless, the protection of the adjacent tissues should be taken into consideration during the total prostate ablation process due to their sensitivity to PDT. The sensitivity of the prostatic urethra is worth further investigation. Direct intraurethral irradiation might provide an ideal means to determine the sensitivity of the prostatic urethra and might lead to transurethral PDT protocols for the management of benign prostatic hyperplasia (BHP).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046488      PMCID: PMC2302792          DOI: 10.1039/b705984a

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  25 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

2.  Anatomy of the pelvic plexus and innervation of the prostate gland.

Authors:  M Ali; I P Johnson; J Hobson; B Mohammadi; F Khan
Journal:  Clin Anat       Date:  2004-03       Impact factor: 2.414

Review 3.  Vascular and cellular targeting for photodynamic therapy.

Authors:  Bin Chen; Brian W Pogue; P Jack Hoopes; Tayyaba Hasan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2006       Impact factor: 1.807

4.  Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.

Authors:  Qun Chen; Zheng Huang; David Luck; Jill Beckers; Pierre-Herve Brun; Brian C Wilson; Avigdor Scherz; Yoram Salomon; Fred W Hetzel
Journal:  Photochem Photobiol       Date:  2002-10       Impact factor: 3.421

5.  Photodynamic therapy in the canine prostate using motexafin lutetium.

Authors:  R A Hsi; A Kapatkin; J Strandberg; T Zhu; T Vulcan; M Solonenko; C Rodriguez; J Chang; M Saunders; N Mason; S Hahn
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

6.  Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery.

Authors:  Smadar Schreiber; Shimon Gross; Alex Brandis; Alon Harmelin; Varda Rosenbach-Belkin; Avigdor Scherz; Yoram Salomon
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

7.  Transperineal photodynamic ablation of the canine prostate.

Authors:  S H Selman; R W Keck; J A Hampton
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

8.  The inferior hypogastric plexus (pelvic plexus): its importance in neural preservation techniques.

Authors:  B Mauroy; X Demondion; A Drizenko; E Goullet; J-L Bonnal; J Biserte; C Abbou
Journal:  Surg Radiol Anat       Date:  2003-04-11       Impact factor: 1.246

9.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Authors:  Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 10.  Photodynamic therapy: a new approach to prostate cancer.

Authors:  Rolf Muschter
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

View more
  12 in total

1.  Photocytotoxicity of the fluorescent nonsteroidal androgen receptor ligand TDPQ.

Authors:  Piotr J Bilski; Boris Risek; Colin F Chignell; William T Schrader
Journal:  Photochem Photobiol       Date:  2009-05-28       Impact factor: 3.421

2.  Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration.

Authors:  Sulbha K Sharma; Michael Krayer; Felipe F Sperandio; Liyi Huang; Ying-Ying Huang; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Porphyr Phthalocyanines       Date:  2013-01       Impact factor: 1.811

3.  Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.

Authors:  Hesheng Wang; Baowei Fei
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

Review 4.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

Review 5.  Recent advances in photodynamic therapy for cancer and infectious diseases.

Authors:  Xutong Shi; Can Yang Zhang; Jin Gao; Zhenjia Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-05-06

6.  Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.

Authors:  Ying-Ying Huang; Thiagarajan Balasubramanian; Eunkyung Yang; Dianzhong Luo; James R Diers; David F Bocian; Jonathan S Lindsey; Dewey Holten; Michael R Hamblin
Journal:  ChemMedChem       Date:  2012-10-12       Impact factor: 3.466

7.  Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model.

Authors:  K E Wright; E Liniker; M Loizidou; C Moore; A J Macrobert; J B Phillips
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

Review 8.  Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Authors:  Zheng Huang; Heping Xu; Arlen D Meyers; Ali I Musani; Luowei Wang; Randall Tagg; Al B Barqawi; Yang K Chen
Journal:  Technol Cancer Res Treat       Date:  2008-08

9.  Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer.

Authors:  Caroline Eymerit-Morin; Merzouka Zidane; Souhil Lebdai; Stéphane Triau; Abdel Rahmene Azzouzi; Marie-Christine Rousselet
Journal:  Virchows Arch       Date:  2013-08-16       Impact factor: 4.064

10.  Focal treatment of prostate cancer with vascular-targeted photodynamic therapy.

Authors:  Scott E Eggener; Jonathan A Coleman
Journal:  ScientificWorldJournal       Date:  2008-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.